SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 64B-69B

ST2 and patient prognosis in chronic heart failure

(3) Bayes Genis, Antoni a,b Zhang, Yuhui c Ky, Bonnie d

a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL (Spain)

b UNIVERSITAT AUTÒNOMA DE BARCELONA (Spain)

c FUWAI HOSPITAL (China)

d UNIVERSITY OF PENNSYLVANIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALECTIN 3; HEMOGLOBIN; ROSUVASTATIN; SODIUM; SUPPRESSION OF TUMORIGENICITY 2; TROPONIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN;

ADVERSE OUTCOME; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; DIABETES MELLITUS; EXERCISE; FOLLOW UP; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; IMMUNOASSAY; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MULTICENTER STUDY (TOPIC); NEW YORK HEART ASSOCIATION CLASS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SUDDEN CARDIAC DEATH; BLOOD; DISEASE COURSE;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; HEART FAILURE; HUMANS; PROGNOSIS; RECEPTORS, CELL SURFACE;

EID: 84924985044 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2015.01.043 Document Type: Article

Times cited : (54)

References (18)

1
- 84880507499
- ST2 as a cardiovascular risk biomarker: From the bench to the bedside
- J.L. Januzzi ST2 as a cardiovascular risk biomarker: from the bench to the bedside J Cardiovasc Trans Res 6 2013 493 500
- (2013) J Cardiovasc Trans Res , vol.6 , pp. 493-500
- Januzzi, J.L.¹

2
- 84907924762
- Using ST2 in cardiovascular patients: A review
- L. Daniels, and A. Bayes-Genis Using ST2 in cardiovascular patients: a review Fut Cardiol 10 2014 525 539
- (2014) Fut Cardiol , vol.10 , pp. 525-539
- Daniels, L.¹ Bayes-Genis, A.²

3
- 84885457377
- 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines
- C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, G.C. Fonarow, S.A. Geraci, T. Horwich, J.L. Januzzi, M.R. Johnson, E.K. Kasper, W.C. Levy, F.A. Masoudi, P.E. McBride, J.J. McMurray, J.E. Mitchell, P.N. Peterson, B. Riegel, F. Sam, L.W. Stevenson, W.H. Tang, E.J. Tsai, B.L. Wilkoff American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 1495 1539
- (2013) J Am Coll Cardiol , vol.62 , pp. 1495-1539
- Yancy, C.W.¹ Jessup, M.² Bozkurt, B.³ Butler, J.⁴ Casey, Jr.D.E.⁵ Drazner, M.H.⁶ Fonarow, G.C.⁷ Geraci, S.A.⁸ Horwich, T.⁹ Januzzi, J.L.¹⁰ Johnson, M.R.¹¹ Kasper, E.K.¹² Levy, W.C.¹³ Masoudi, F.A.¹⁴ McBride, P.E.¹⁵ McMurray, J.J.¹⁶ Mitchell, J.E.¹⁷ Peterson, P.N.¹⁸ Riegel, B.¹⁹ Sam, F.²⁰ more..

4
- 79955943158
- High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure
- B. Ky, B. French, K. Mccloskey, J.E. Rame, E. McIntosh, P. Shahi, D.L. Dries, W.H. Tang, A.H. Wu, J.C. Fang, R. Boxer, N.K. Sweitzer, W.C. Levy, L.R. Goldberg, M. Jessup, and T.P. Cappola High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure Circ Heart Fail 4 2011 180 187
- (2011) Circ Heart Fail , vol.4 , pp. 180-187
- Ky, B.¹ French, B.² McCloskey, K.³ Rame, J.E.⁴ McIntosh, E.⁵ Shahi, P.⁶ Dries, D.L.⁷ Tang, W.H.⁸ Wu, A.H.⁹ Fang, J.C.¹⁰ Boxer, R.¹¹ Sweitzer, N.K.¹² Levy, W.C.¹³ Goldberg, L.R.¹⁴ Jessup, M.¹⁵ Cappola, T.P.¹⁶

5
- 0037432179
- Identification of serum soluble ST2 receptor as a novel heart failure biomarker
- E.O. Weinberg, M. Shimpo, S. Hurwitz, S. Tominaga, J.L. Rouleau, and R.T. Lee Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 2003 721 726
- (2003) Circulation , vol.107 , pp. 721-726
- Weinberg, E.O.¹ Shimpo, M.² Hurwitz, S.³ Tominaga, S.⁴ Rouleau, J.L.⁵ Lee, R.T.⁶

6
- 84555204703
- Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure
- A. Bayes-Genis, M. De Antonio, A. Galan, H. Sanz, A. Urrutia, R. Cabanes, L. Cano, B. González, C. Díez, T. Pascual, R. Elosúa, and J. Lupón Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure Eur J Heart Fail 14 2012 32 38
- (2012) Eur J Heart Fail , vol.14 , pp. 32-38
- Bayes-Genis, A.¹ De Antonio, M.² Galan, A.³ Sanz, H.⁴ Urrutia, A.⁵ Cabanes, R.⁶ Cano, L.⁷ González, B.⁸ Díez, C.⁹ Pascual, T.¹⁰ Elosúa, R.¹¹ Lupón, J.¹²

7
- 84888056391
- Soluble ST2 serum concentration and renal function in heart failure
- A. Bayes-Genis, E. Zamora, M. De Antonio, A. Galán, J. Vila, A. Urrutia, C. Díez, R. Coll, S. Altimir, and J. Lupón Soluble ST2 serum concentration and renal function in heart failure J Card Fail 19 2013 768 775
- (2013) J Card Fail , vol.19 , pp. 768-775
- Bayes-Genis, A.¹ Zamora, E.² De Antonio, M.³ Galán, A.⁴ Vila, J.⁵ Urrutia, A.⁶ Díez, C.⁷ Coll, R.⁸ Altimir, S.⁹ Lupón, J.¹⁰

8
- 84856071476
- Emerging biomarkers in heart failure
- R.R.J. van Kimmenade, and J.L. Januzzi Jr. Emerging biomarkers in heart failure Clin Chem 58 2012 127 138
- (2012) Clin Chem , vol.58 , pp. 127-138
- Van Kimmenade, R.R.J.¹ Januzzi, Jr.J.L.²

9
- 78651387589
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
- R.A. De Boer, D.J. Lok, T. Jaarsma, P. van der Meer, A.A. Voors, H.L. Hillege, and D.J. van Veldhuisen Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Ann Med 43 2011 60 68
- (2011) Ann Med , vol.43 , pp. 60-68
- De Boer, R.A.¹ Lok, D.J.² Jaarsma, T.³ Van Der Meer, P.⁴ Voors, A.A.⁵ Hillege, H.L.⁶ Van Veldhuisen, D.J.⁷

10
- 84892415130
- Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3
- A. Bayes-Genis, M. de Antonio, J. Vila, J. Peñafiel, A. Galán, J. Barallat, E. Zamora, A. Urrutia, and J. Lupón Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3 J Am Coll Cardiol 63 2014 158 166
- (2014) J Am Coll Cardiol , vol.63 , pp. 158-166
- Bayes-Genis, A.¹ De Antonio, M.² Vila, J.³ Peñafiel, J.⁴ Galán, A.⁵ Barallat, J.⁶ Zamora, E.⁷ Urrutia, A.⁸ Lupón, J.⁹

11
- 70449846683
- Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systoloic dysfunction
- MUSIC Investigators
- D.A. Pascual-Figal, J. Ordoñez-Llanos, P.L. Tornel, R. Vazquez, T. Puig, M. Valdes, J. Cinca, A.B. de Luna, A. Bayes-Genis MUSIC Investigators Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systoloic dysfunction J Am Coll Cardiol 54 2009 2174 2179
- (2009) J Am Coll Cardiol , vol.54 , pp. 2174-2179
- Pascual-Figal, D.A.¹ Ordoñez-Llanos, J.² Tornel, P.L.³ Vazquez, R.⁴ Puig, T.⁵ Valdes, M.⁶ Cinca, J.⁷ De Luna, A.B.⁸ Bayes-Genis, A.⁹

12
- 17644418784
- Prediction and prevention of sudden cardiac death in heart failure
- R.E. Lane, M.R. Cowie, and A.W.C. Chow Prediction and prevention of sudden cardiac death in heart failure Heart 91 2005 674 680
- (2005) Heart , vol.91 , pp. 674-680
- Lane, R.E.¹ Cowie, M.R.² Chow, A.W.C.³

13
- 53249113212
- The IL-33/ST2 pathway: Therapeutic target and novel biomarker
- R. Rakkar, and R.T. Lee The IL-33/ST2 pathway: therapeutic target and novel biomarker Nat Rev Drug Discov 7 2008 827 840
- (2008) Nat Rev Drug Discov , vol.7 , pp. 827-840
- Rakkar, R.¹ Lee, R.T.²

14
- 84892644062
- Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes
- G.M. Felker, M. Fiuzat, V. Thompson, L.K. Shaw, M.L. Neely, K.F. Adams, D.J. Whellan, M.P. Donahue, T. Ahmad, D.W. Kitzman, I.L. Piña, F. Zannad, W.E. Kraus, and C.M. O'Connor Soluble ST2 in ambulatory patients with heart failure: association with functional capacity and long-term outcomes Circ Heart Fail 6 2013 1172 1179
- (2013) Circ Heart Fail , vol.6 , pp. 1172-1179
- Felker, G.M.¹ Fiuzat, M.² Thompson, V.³ Shaw, L.K.⁴ Neely, M.L.⁵ Adams, K.F.⁶ Whellan, D.J.⁷ Donahue, M.P.⁸ Ahmad, T.⁹ Kitzman, D.W.¹⁰ Piña, I.L.¹¹ Zannad, F.¹² Kraus, W.E.¹³ O'Connor, C.M.¹⁴

15
- 84857609914
- Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
- K. Broch, T. Ueland, S.H. Nymo, J. Kjekshus, J. Hulthe, P. Muntendam, J.J. McMurray, J. Wikstrand, J.G. Cleland, P. Aukrust, and L. Gullestad Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology Eur J Heart Fail 14 2012 268 277
- (2012) Eur J Heart Fail , vol.14 , pp. 268-277
- Broch, K.¹ Ueland, T.² Nymo, S.H.³ Kjekshus, J.⁴ Hulthe, J.⁵ Muntendam, P.⁶ McMurray, J.J.⁷ Wikstrand, J.⁸ Cleland, J.G.⁹ Aukrust, P.¹⁰ Gullestad, L.¹¹

16
- 84894070849
- Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
- D. Gruson, T. Lepoutre, S.A. Ahn, and M.F. Rousseau Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction Int J Cardiol 172 2014 e250 e252
- (2014) Int J Cardiol , vol.172 , pp. e250-e252
- Gruson, D.¹ Lepoutre, T.² Ahn, S.A.³ Rousseau, M.F.⁴

17
- 77957848557
- Association of ST2 levels with cardiac structure and function and mortality in outpatients
- L.B. Daniels, P. Clopton, N. Iqbal, K. Tran, and A.S. Maisel Association of ST2 levels with cardiac structure and function and mortality in outpatients Am Heart J 160 2010 721 728
- (2010) Am Heart J , vol.160 , pp. 721-728
- Daniels, L.B.¹ Clopton, P.² Iqbal, N.³ Tran, K.⁴ Maisel, A.S.⁵

18
- 78649291119
- Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure
- A. Bayes-Genis, D. Pascual-Figal, J.L. Januzzi, A. Maisel, T. Casas, M. Valdés Chávarri, and J. Ordóñez-Llanos Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure Rev Esp Cardiol 63 2010 1171 1178
- (2010) Rev Esp Cardiol , vol.63 , pp. 1171-1178
- Bayes-Genis, A.¹ Pascual-Figal, D.² Januzzi, J.L.³ Maisel, A.⁴ Casas, T.⁵ Valdés Chávarri, M.⁶ Ordóñez-Llanos, J.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.